Cannabis company Green Thumb beats revenue estimate but posts loss on noncash impairment

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

CEO Ben Kovler says the company grew its cash from the previous quarter but that 'nothing is a straight line' when it comes to state-by-state legalization.

Green Thumb Industries Inc. posted a fourth-quarter loss on noncash impairments but managed to beat its revenue target as it built up its balance sheet despite headwinds in the sector.The company late Tuesday said it lost $51.22 million, or 22 cents a share, in the fourth quarter,... Green Thumb Industries Inc. posted a fourth-quarter loss on noncash impairments but managed to beat its revenue target as it built up its balance sheet despite headwinds in the sector.

Excluding these items, Green Thumb earned 5 cents a share, a penny short of the estimate of 6 cents a share in an analyst survey by FactSet.“The lack of progress regarding cannabis regulation from our elected officials in Congress is mind-numbing,” said CEO Ben Kovler, adding that the companies face high tax burdens.

“The industry is entering the middle innings,” Kovler said, with some mature markets and others opening up. He added that “nothing is a straight line” in legalization, with steps both forward and back in many states. Green Thumb ended the fourth quarter with $178 million in cash, up $31 million from the third quarter but down $52 million from a year ago.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cowen drops coverage of U.S. pot stocks on acquisition by Toronto-Dominion BankCowen analyst Vivien Azur will continue analysis of cannabis sector but will no longer follow seven stocks including Curaleaf, Green Thumb and Trulieve.
Source: MarketWatch - 🏆 3. / 97 Read more »